Annual Retained Earnings
-$215.01 M
-$17.19 M-8.69%
December 31, 2023
Summary
- As of February 23, 2025, BCLI annual retained earnings is -$215.01 million, with the most recent change of -$17.19 million (-8.69%) on December 31, 2023.
- During the last 3 years, BCLI annual retained earnings has fallen by -$65.93 million (-44.22%).
- BCLI annual retained earnings is now -504625.35% below its all-time high of -$42.60 thousand, reached on March 31, 2002.
Performance
BCLI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$223.66 M
-$2.71 M-1.23%
September 30, 2024
Summary
- As of February 23, 2025, BCLI quarterly retained earnings is -$223.66 million, with the most recent change of -$2.71 million (-1.23%) on September 30, 2024.
- Over the past year, BCLI quarterly retained earnings has stayed the same.
- BCLI quarterly retained earnings is now -436741.80% below its all-time high of -$51.20 thousand, reached on June 30, 2002.
Performance
BCLI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
BCLI Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.7% | 0.0% |
| 3 y3 years | -44.2% | 0.0% |
| 5 y5 years | -128.7% | 0.0% |
BCLI Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.9% | at low | -28.9% | at low |
| 5 y | 5-year | -83.3% | at low | -90.7% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Brainstorm Cell Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$223.66 M(+1.2%) |
| Jun 2024 | - | -$220.96 M(+1.2%) |
| Mar 2024 | - | -$218.41 M(+1.6%) |
| Dec 2023 | -$215.01 M(+8.7%) | -$215.01 M(+2.7%) |
| Sep 2023 | - | -$209.44 M(+0.6%) |
| Jun 2023 | - | -$208.21 M(+2.6%) |
| Mar 2023 | - | -$202.88 M(+2.6%) |
| Dec 2022 | -$197.82 M(+14.0%) | -$197.82 M(+2.6%) |
| Sep 2022 | - | -$192.80 M(+3.7%) |
| Jun 2022 | - | -$185.94 M(+3.9%) |
| Mar 2022 | - | -$178.90 M(+3.1%) |
| Dec 2021 | -$173.54 M(+16.4%) | -$173.54 M(+3.7%) |
| Sep 2021 | - | -$167.35 M(+3.3%) |
| Jun 2021 | - | -$162.02 M(+4.0%) |
| Mar 2021 | - | -$155.75 M(+4.5%) |
| Dec 2020 | -$149.09 M(+27.1%) | -$149.09 M(+8.6%) |
| Sep 2020 | - | -$137.27 M(+3.4%) |
| Jun 2020 | - | -$132.78 M(+5.9%) |
| Mar 2020 | - | -$125.39 M(+6.9%) |
| Dec 2019 | -$117.28 M(+24.7%) | -$117.28 M(+7.0%) |
| Sep 2019 | - | -$109.58 M(+5.4%) |
| Jun 2019 | - | -$103.95 M(+4.9%) |
| Mar 2019 | - | -$99.05 M(+5.3%) |
| Dec 2018 | -$94.02 M(+17.4%) | -$94.02 M(+6.1%) |
| Sep 2018 | - | -$88.64 M(+3.7%) |
| Jun 2018 | - | -$85.46 M(+3.8%) |
| Mar 2018 | - | -$82.37 M(+2.9%) |
| Dec 2017 | -$80.08 M(+6.6%) | -$80.08 M(-0.3%) |
| Sep 2017 | - | -$80.35 M(+3.1%) |
| Jun 2017 | - | -$77.95 M(+1.4%) |
| Mar 2017 | - | -$76.91 M(+2.4%) |
| Dec 2016 | -$75.12 M(+7.1%) | -$75.12 M(+0.8%) |
| Sep 2016 | - | -$74.50 M(+2.2%) |
| Jun 2016 | - | -$72.89 M(+1.3%) |
| Mar 2016 | - | -$71.93 M(+2.6%) |
| Dec 2015 | -$70.14 M(+13.8%) | -$70.14 M(+2.0%) |
| Sep 2015 | - | -$68.76 M(+3.9%) |
| Jun 2015 | - | -$66.15 M(+3.5%) |
| Mar 2015 | - | -$63.89 M(+3.6%) |
| Dec 2014 | -$61.65 M(+17.6%) | -$61.65 M(+4.6%) |
| Sep 2014 | - | -$58.92 M(+4.3%) |
| Jun 2014 | - | -$56.50 M(+3.6%) |
| Mar 2014 | - | -$54.52 M(+4.0%) |
| Dec 2013 | -$52.41 M | -$52.41 M(+2.4%) |
| Sep 2013 | - | -$51.19 M(+2.2%) |
| Jun 2013 | - | -$50.11 M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | -$48.59 M(+2.3%) |
| Dec 2012 | -$47.51 M(+7.8%) | -$47.51 M(+1.2%) |
| Sep 2012 | - | -$46.93 M(+2.5%) |
| Jun 2012 | - | -$45.78 M(+1.8%) |
| Mar 2012 | - | -$44.95 M(+2.0%) |
| Dec 2011 | -$44.08 M(+9.8%) | -$44.08 M(+3.3%) |
| Sep 2011 | - | -$42.66 M(+1.7%) |
| Jun 2011 | - | -$41.96 M(+2.7%) |
| Mar 2011 | - | -$40.87 M(+1.8%) |
| Dec 2010 | -$40.16 M(+6.4%) | -$40.16 M(+1.2%) |
| Sep 2010 | - | -$39.67 M(+1.8%) |
| Jun 2010 | - | -$38.97 M(+1.6%) |
| Mar 2010 | - | -$38.36 M(+1.6%) |
| Dec 2009 | -$37.74 M(+5.0%) | -$37.74 M(+0.3%) |
| Sep 2009 | - | -$37.64 M(+1.7%) |
| Jun 2009 | - | -$37.02 M(+1.5%) |
| Mar 2009 | - | -$36.47 M(+1.4%) |
| Dec 2008 | -$35.96 M(+10.7%) | -$35.96 M(+1.8%) |
| Sep 2008 | - | -$35.33 M(+2.1%) |
| Jun 2008 | - | -$34.61 M(+2.5%) |
| Mar 2008 | - | -$33.75 M(+3.9%) |
| Dec 2007 | -$32.49 M(+23.8%) | -$32.49 M(+6.2%) |
| Sep 2007 | - | -$30.58 M(+5.0%) |
| Jun 2007 | - | -$29.12 M(+4.1%) |
| Mar 2007 | - | -$27.97 M(+15.5%) |
| Dec 2006 | -$26.24 M(+17.6%) | - |
| Sep 2006 | - | -$24.22 M(+4.5%) |
| Jun 2006 | - | -$23.17 M(+3.8%) |
| Mar 2006 | - | -$22.32 M(+2.8%) |
| Mar 2006 | -$22.32 M(+17.5%) | - |
| Dec 2005 | - | -$21.70 M(+4.4%) |
| Sep 2005 | - | -$20.78 M(+5.3%) |
| Jun 2005 | - | -$19.74 M(+3.9%) |
| Mar 2005 | -$19.00 M(>+9900.0%) | -$19.00 M(+3.1%) |
| Dec 2004 | - | -$18.44 M(+960.4%) |
| Sep 2004 | - | -$1.74 M(+1126.3%) |
| Jun 2004 | - | -$141.80 K(-12.8%) |
| Mar 2004 | -$162.70 K(+82.0%) | -$162.70 K(+28.2%) |
| Dec 2003 | - | -$126.90 K(+13.0%) |
| Sep 2003 | - | -$112.30 K(+10.9%) |
| Jun 2003 | - | -$101.30 K(+13.3%) |
| Mar 2003 | -$89.40 K(+109.9%) | -$89.40 K(+22.6%) |
| Dec 2002 | - | -$72.90 K(+22.7%) |
| Sep 2002 | - | -$59.40 K(+16.0%) |
| Jun 2002 | - | -$51.20 K |
| Mar 2002 | -$42.60 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual retained earnings year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly retained earnings year-on-year change?
What is Brainstorm Cell Therapeutics annual retained earnings?
The current annual retained earnings of BCLI is -$215.01 M
What is the all time high annual retained earnings for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual retained earnings is -$42.60 K
What is Brainstorm Cell Therapeutics annual retained earnings year-on-year change?
Over the past year, BCLI annual retained earnings has changed by -$17.19 M (-8.69%)
What is Brainstorm Cell Therapeutics quarterly retained earnings?
The current quarterly retained earnings of BCLI is -$223.66 M
What is the all time high quarterly retained earnings for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly retained earnings is -$51.20 K
What is Brainstorm Cell Therapeutics quarterly retained earnings year-on-year change?
Over the past year, BCLI quarterly retained earnings has changed by $0.00 (0.00%)